Brookstone Capital Management Raises Stock Position in Veeva Systems Inc. $VEEV

Brookstone Capital Management lifted its position in Veeva Systems Inc. (NYSE:VEEV) by 9.0% during the second quarter, Holdings Channel reports. The institutional investor owned 1,293 shares of the technology company’s stock after buying an additional 107 shares during the quarter. Brookstone Capital Management’s holdings in Veeva Systems were worth $372,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of VEEV. GAMMA Investing LLC grew its position in shares of Veeva Systems by 13.8% in the 1st quarter. GAMMA Investing LLC now owns 1,823 shares of the technology company’s stock worth $422,000 after buying an additional 221 shares during the last quarter. Spire Wealth Management raised its stake in Veeva Systems by 37.1% in the first quarter. Spire Wealth Management now owns 277 shares of the technology company’s stock valued at $64,000 after buying an additional 75 shares during the last quarter. Bessemer Group Inc. raised its stake in Veeva Systems by 4.9% in the first quarter. Bessemer Group Inc. now owns 2,379 shares of the technology company’s stock valued at $551,000 after buying an additional 111 shares during the last quarter. Golden State Wealth Management LLC raised its stake in Veeva Systems by 152.9% in the first quarter. Golden State Wealth Management LLC now owns 129 shares of the technology company’s stock valued at $30,000 after buying an additional 78 shares during the last quarter. Finally, Perigon Wealth Management LLC raised its stake in Veeva Systems by 4.9% in the first quarter. Perigon Wealth Management LLC now owns 2,188 shares of the technology company’s stock valued at $507,000 after buying an additional 103 shares during the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Veeva Systems Price Performance

VEEV stock opened at $295.64 on Tuesday. The firm’s fifty day simple moving average is $284.95 and its 200-day simple moving average is $270.59. The company has a market capitalization of $48.46 billion, a P/E ratio of 60.71, a price-to-earnings-growth ratio of 2.26 and a beta of 0.98. Veeva Systems Inc. has a 12 month low of $201.54 and a 12 month high of $310.50.

Veeva Systems (NYSE:VEEV) last posted its earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.90 by ($0.64). Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The firm had revenue of $789.08 million during the quarter, compared to analyst estimates of $768.49 million. During the same quarter in the prior year, the firm earned $1.62 earnings per share. The business’s revenue for the quarter was up 16.7% on a year-over-year basis. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. As a group, sell-side analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Wells Fargo & Company boosted their target price on shares of Veeva Systems from $300.00 to $326.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 26th. Canaccord Genuity Group boosted their target price on shares of Veeva Systems from $270.00 to $300.00 and gave the stock a “hold” rating in a research report on Thursday, August 28th. Piper Sandler boosted their target price on shares of Veeva Systems from $325.00 to $355.00 and gave the stock an “overweight” rating in a research report on Thursday, August 28th. Citigroup boosted their target price on shares of Veeva Systems from $329.00 to $349.00 and gave the stock a “buy” rating in a research report on Thursday, August 28th. Finally, Oppenheimer reissued an “outperform” rating and set a $325.00 target price on shares of Veeva Systems in a research report on Thursday, August 28th. Seventeen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Veeva Systems has an average rating of “Moderate Buy” and an average price target of $307.58.

Insider Activity at Veeva Systems

In related news, insider Eleni Nitsa Zuppas sold 6,000 shares of the business’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the transaction, the insider directly owned 25,325 shares in the company, valued at $7,765,151.50. The trade was a 19.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Thomas D. Schwenger sold 3,350 shares of the business’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the completion of the transaction, the insider owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 in the last three months. Company insiders own 10.30% of the company’s stock.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.